Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
European Journal of Pharmacology
|
January 20, 1987
CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben
R W Olson, D S Cohen, E C Ku, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 17, 2006
Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors
Tsung H Lin, Axel Metzger, David J Diller, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors
Y Satoh, J L Stanton, A J Hutchison, et al.
Arzneimittel-Forschung
|
September 1, 1992
Hypolipidaemic activity of a novel acyclic ansamycin derivative. Synthesis and pharmacokinetic and pharmacodynamic studies in rodents
K A Menear, K E Dunnet, J G Hastewell, et al.
Biochimica Et Biophysica Acta
|
April 15, 1988
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models
E C Ku, A Raychaudhuri, G Ghai, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 1, 1997
Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model
A Raychaudhuri, H Chertock, J Chovan, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1989
Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor
E C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
January 24, 2009
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2
J N King, J Dawson, R E Esser, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2010
Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists
Brian F McGuinness, Andrew G Cole, Guizhen Dong, et al.
British Journal of Pharmacology
|
January 19, 2005
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2
Ronald Esser, Carol Berry, Zhengming Du, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
European Journal of Pharmacology
|
January 20, 1987
CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben
R W Olson, D S Cohen, E C Ku, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 17, 2006
Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors
Tsung H Lin, Axel Metzger, David J Diller, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors
Y Satoh, J L Stanton, A J Hutchison, et al.
Arzneimittel-Forschung
|
September 1, 1992
Hypolipidaemic activity of a novel acyclic ansamycin derivative. Synthesis and pharmacokinetic and pharmacodynamic studies in rodents
K A Menear, K E Dunnet, J G Hastewell, et al.
Biochimica Et Biophysica Acta
|
April 15, 1988
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models
E C Ku, A Raychaudhuri, G Ghai, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 1, 1997
Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model
A Raychaudhuri, H Chertock, J Chovan, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1989
Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor
E C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
January 24, 2009
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2
J N King, J Dawson, R E Esser, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2010
Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists
Brian F McGuinness, Andrew G Cole, Guizhen Dong, et al.
British Journal of Pharmacology
|
January 19, 2005
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2
Ronald Esser, Carol Berry, Zhengming Du, et al.
Page
of 3